Not exactly, but it certainly raises the possibility. A wide-ranging analysis published to little initial fanfare on December 1 reviewed Medicare data for outcomes for more than 30 million recipients of Pfizer’s COVID vaccine above the age of 65. The first pass of the data showed “statistical signals” to four potential adverse outcomes, but subsequent reviews limited the signal to just one: a potential causal link between this particular vaccine and a type of pulmonary embolism:Read More
Does a new study show Pfizer’s COVID vaccine causes blood clotting?
